ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Three Periodontal Therapies in Current Smokers and Non-Smokers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00066066
Recruitment Status : Completed
First Posted : August 5, 2003
Results First Posted : April 22, 2013
Last Update Posted : April 22, 2013
Sponsor:
Collaborator:
National Institute of Dental and Craniofacial Research (NIDCR)
Information provided by (Responsible Party):
The Forsyth Institute

Study Type: Interventional
Study Design: Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor);   Primary Purpose: Treatment
Conditions: Periodontitis
Periodontal Diseases
Interventions: Procedure: Scaling and root planing
Drug: Metronidazole
Drug: Amoxicillin
Drug: Doxycycline

  Participant Flow


  Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
  Description
Scaling and Root Planing (SRP) Only Subjects received full mouth scaling and root planing (SRP) under local anesthesia.Maintenance SRP was performed every 3 months for the duration of the study in all subjects.
SRP and Metronidazole (MET)

In addition to full mouth scaling and root planing under local anesthesia,subjects received systemically administered metronidazole (250 mg tid x 14 days). Maintenance SRP was performed every 3 months for the duration of the study in all subjects.

Metronidazole is an antibiotic that is particularly effective against Gram negative bacterial species.

SRP and Amoxicillin, MET and Locally Delivered Tetracycline

In addition to full mouth scaling and root planing under local anesthesia,subjects received systemically administered metronidazole (250 mg tid x 14 days) together with systemically administered amoxicillin (500 mg tid for 14 days) and local delivery of doxycycline (Atridox) at teeth with pockets > 4 mm. Maintenance SRP was performed every 3 months for the duration of the study in all subjects.

Tetracycline : Tetracycline is an antibiotic that has proved effective in killing bacteria in the periodontal pocket when applied locally.

Total Total of all reporting groups

Baseline Measures
   Scaling and Root Planing (SRP) Only   SRP and Metronidazole (MET)   SRP and Amoxicillin, MET and Locally Delivered Tetracycline   Total 
Overall Participants Analyzed 
[Units: Participants]
 49   50   47   146 
Age 
[Units: Participants]
       
<=18 years   0   0   0   0 
Between 18 and 65 years   42   46   44   132 
>=65 years   7   4   3   14 
Age 
[Units: Years]
Mean (Standard Deviation)
 50.3  (11.8)   50.3  (11.6)   48.0  (11.1)   49.5  (11.5) 
Gender 
[Units: Participants]
       
Female   21   23   20   64 
Male   28   27   27   82 
Region of Enrollment 
[Units: Participants]
       
United States   49   50   47   146 


  Outcome Measures

1.  Primary:   Change in Mean Clinical Attachment Level.   [ Time Frame: Baseline, 3, 6 and 12 months ]


  Serious Adverse Events


  Other Adverse Events


  Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.


  More Information

Certain Agreements:  
All Principal Investigators ARE employed by the organization sponsoring the study.


Results Point of Contact:  
Name/Title: Ricardo P Teles, DDS, DMSc
Organization: The Forsyth Institute
phone: 617 892-8556
e-mail: rteles@forsyth.org



Responsible Party: The Forsyth Institute
ClinicalTrials.gov Identifier: NCT00066066     History of Changes
Other Study ID Numbers: NIDCR-14242
R01DE014242 ( U.S. NIH Grant/Contract )
First Submitted: August 1, 2003
First Posted: August 5, 2003
Results First Submitted: December 11, 2012
Results First Posted: April 22, 2013
Last Update Posted: April 22, 2013